Federal Register / Vol. 87, No. 99 / Monday, May 23, 2022 / Notices 31245 

Dated: May 17, 2022. 

Alison Barkoff, 

Acting Administrator and Assistant Secretary 

for Aging. 

[FR Doc. 2022–10987 Filed 5–20–22; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2022–N–0619] 

Advisory Committee; Gastrointestinal 

Drugs Advisory Committee; Renewal; 

Correction 

AGENCY: Food and Drug Administration, 

HHS 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration (FDA) is correcting a 

notice entitled ‘‘Advisory Committee; 

Gastrointestinal Drugs Advisory 

Committee; Renewal’’ that appeared in 

the Federal Register of May 11, 2022. 

The document announced the renewal 

of the Gastrointestinal Drugs Advisory 

Committee. The document was 

published with the incorrect docket 

number. This document corrects that 

error. 

FOR FURTHER INFORMATION CONTACT: 

Rhea Bhatt, Division of Advisory 

Committee and Consultant 

Management, Center for Drug 

Evaluation and Research, Food and 

Drug Administration, 10903 New 

Hampshire Ave., Bldg. 31, Rm. 2434, 

Silver Spring, MD 20993–0002, 301– 

796–9001, email: GIDAC@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of Wednesday, May 11, 

2022 (87 FR 28834), in FR Doc. 2022– 

10040, on page 28834, the following 

correction is made: 

1. On page 28834, in the first column 

of the header of the document, ‘‘Docket 

No. FDA–2021–N–0619’’ is corrected to 

read ‘‘Docket No. FDA–2022–N–0619’’. 

Dated: May 13, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–10941 Filed 5–20–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Presidential Advisory 

Council on Combating AntibioticResistant Bacteria 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that a meeting is scheduled to be held 

for the Presidential Advisory Council on 

Combating Antibiotic-Resistant Bacteria 

(PACCARB). The meeting will be open 

to the public; a pre-registered public 

comment session will be held during 

the meeting. Pre-registration is required 

for members of the public who wish to 

attend the meeting and who wish to 

participate in the public comment 

session. Individuals who wish to attend 

the meeting and/or send in their public 

comment via email should send an 

email to CARB@hhs.gov. Registration 

information is available on the website 

http://www.hhs.gov/paccarb and must 

be completed by September 5, 2022; all 

in-person attendees must pre-register by 

this date and will be given priority over 

unregistered attendees. Additional 

information about any updates to 

COVID–19 safety precautions or 

requirements, including how to register 

for the meeting and provide public 

comment, can be obtained at http://

www.hhs.gov/paccarb on the Meetings 

page. Please visit the page for frequent 

updates. 

DATES: The meeting is tentatively 

scheduled to be held on September 12, 

from 9:00 a.m. to 5:00 p.m., and 

September 13, 2022, from 9:00 a.m. to 

5:00 p.m. ET (all times are subject to 

change). The confirmed times and 

agenda items for the meeting will be 

posted on the website for the PACCARB 

at http://www.hhs.gov/paccarb when 

this information becomes available. Preregistration for attending the meeting in 

person is required to be completed no 

later than September 5, 2022; public 

attendance at the meeting is limited to 

the available space. 

ADDRESSES: Tysons Corner Marriott, 

8028 Leesburg Pike, Tysons Corner, 

Virginia 22182. The meeting can also be 

accessed through a live webcast and via 

teleconference on the day of the 

meeting. For more information, visit 

http://www.hhs.gov/paccarb. 

FOR FURTHER INFORMATION CONTACT: 

Jomana Musmar, M.S., Ph.D., 

Designated Federal Officer, Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria, Office of 

the Assistant Secretary for Health, U.S. 

Department of Health and Human 

Services, Room L616, Switzer Building, 

330 C St. SW, Washington, DC 20201. 

Email: CARB@hhs.gov. Telephone: (202) 

746–1512. 

SUPPLEMENTARY INFORMATION: The 

Presidential Advisory Council on 

Combating Antibiotic-Resistant Bacteria 

(PACCARB), established by Executive 

Order 13676, is continued by Section 

505 of Public Law 116–22, the 

Pandemic and All-Hazards 

Preparedness and Advancing Innovation 

Act of 2019 (PAHPAIA). Activities and 

duties of the Advisory Council are 

governed by the provisions of the 

Federal Advisory Committee Act 

(FACA), Public Law 92–463, as 

amended (5 U.S.C. App.), which sets 

forth standards for the formation and 

use of federal advisory committees. 

The PACCARB shall advise and 

provide information and 

recommendations to the Secretary 

regarding programs and policies 

intended to reduce or combat antibioticresistant bacteria that may present a 

public health threat and improve 

capabilities to prevent, diagnose, 

mitigate, or treat such resistance. The 

PACCARB shall function solely for 

advisory purposes. 

Such advice, information, and 

recommendations may be related to 

improving: The effectiveness of 

antibiotics; research and advanced 

research on, and the development of, 

improved and innovative methods for 

combating or reducing antibiotic 

resistance, including new treatments, 

rapid point-of-care diagnostics, 

alternatives to antibiotics, including 

alternatives to animal antibiotics, and 

antimicrobial stewardship activities; 

surveillance of antibiotic-resistant 

bacterial infections, including publicly 

available and up-to-date information on 

resistance to antibiotics; education for 

health care providers and the public 

with respect to up-to-date information 

on antibiotic resistance and ways to 

reduce or combat such resistance to 

antibiotics related to humans and 

animals; methods to prevent or reduce 

the transmission of antibiotic-resistant 

bacterial infections; including 

stewardship programs; and coordination 

with respect to international efforts in 

order to inform and advance the United 

States capabilities to combat antibiotic 

resistance. 

The September 12–13, 2022 public 

meeting will be dedicated to a One 

Health AMR and Pandemic 

Preparedness Policy Workshop with the 

goal of identifying key issues and 

critical policy gaps through a series of 

facilitated discussions examining a 

hypothetical large-scale disease 

outbreak scenario based on historic 

examples and estimates of future AMR 


lotter on DSK11XQN23PROD with NOTICES1